KITASATO UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.kitasato-u.ac.jp
Clinical Trials
164
Active:0
Completed:109
Trial Phases
5 Phases
Phase 1:1
Phase 2:7
Phase 3:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (162 trials with phase data)• Click on a phase to view related trials
Not Applicable
150 (92.6%)Phase 2
7 (4.3%)Phase 3
3 (1.9%)Phase 1
1 (0.6%)Phase 4
1 (0.6%)Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation
Not Applicable
Recruiting
- Conditions
- Persistent Atrial Fibrillation
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Kitasato University
- Target Recruit Count
- 260
- Registration Number
- NCT07064616
- Locations
- 🇯🇵
Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
Kitasato PCI Registry
Recruiting
- Conditions
- NSTEMI - Non-ST-Segment Elevation Myocardial InfarctionAcute Coronary SyndromeAtherosclerosisCoronary; IschemicStable AnginaSTEMI - ST-segment Elevation Myocardial Infarction
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Kitasato University
- Target Recruit Count
- 4500
- Registration Number
- NCT05308329
- Locations
- 🇯🇵
Kitasato University Hospital, Sagamihara, Kanagawa, Japan
Study in COvid-19 Patients With iveRmectin (CORVETTE-01)
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- Kitasato University
- Target Recruit Count
- 214
- Registration Number
- NCT04703205
- Locations
- 🇯🇵
Kitasato University, Sagamihara, Kanagawa, Japan
First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation
Phase 2
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Drug: M201-A InjectionDrug: Placebo
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Kitasato University
- Target Recruit Count
- 42
- Registration Number
- NCT04609059
- Locations
- 🇯🇵
Koga general Hospital, Koga-City, Ibaraki, Japan
🇯🇵Kitasato University Hospital, Sagamihara-city, Kanagawa, Japan
🇯🇵Sendai Cardiovascular Center, Sendai-city, Miyagi, Japan
Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: M201-A InjectionDrug: Placebo
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- Kitasato University
- Target Recruit Count
- 18
- Registration Number
- NCT04464681
- Locations
- 🇯🇵
Clinical Trial Center, Department of Research, KITASATO UNIVERSITY KITASATO INSTITUTE HOSPITAL, Tokyo, Japan
- Prev
- 1
- 2
- Next
News
No news found